Clinical Trials Browser

Has results × Glioblastoma × sargramostim × Clear all

NCT02455557 2026-02-25

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 2 Active not recruiting

66 enrolled 11 charts

Glioblastoma, Gliosarcoma

NCT04013672 2024-08-28

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Phase 2 Completed

41 enrolled 15 charts

Glioblastoma

NCT03927222 2024-04-08

I-ATTAC

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

NCT00643097 2017-02-01

ACTIVATe

Phase 2 Completed

40 enrolled 9 charts

Glioblastoma, Gliosarcoma